Maharashtra FDA Cancels Cipla Pharma's C&F Drug Licences in Pune Over Regulatory Violations
Maharashtra FDA has cancelled Cipla Pharma & Life Sciences’ C&F drug sale and distribution licences at Vadki, Pune, citing violations linked to misbranded ‘Reactin Plus’ tablets, storage deficiencies, inventory discrepancies and non-compliance with recall directions.
Drugs And Cosmetics Act | 31/08/2026 | By News Bureau | 133
Centre Revises Drugs Rules for Cell and Gene Therapies
The Centre has amended the Drugs Rules, 1945 to bring advanced cell and gene therapies under the Centrally License Approving Authority (CLAA), to include cell and stem cell-derived products, gene therapeutics and xenografts.
Drugs And Cosmetics Act | 03/07/2026 | By News Bureau
Telangana DCA Busts Illegal Sale of Codeine and Tramadol-Based Drugs in Medchal-Malkajgiri
The Telangana Drugs Control Administration conducted a raid on a pharmacy in Medchal-Malkajgiri district, seizing codeine-based cough syrups and tramadol-containing capsules being sold in violation of drug regulations.
Drugs And Cosmetics Act | 04/06/2026 | By News Bureau | 132
India Restricts Import of Refurbished Medical Devices Due to Regulatory Gaps
This move highlights India's stringent approach toward medical device regulation, ensuring that only new, certified devices meeting quality and safety standards enter the market.
Drugs And Cosmetics Act | 20/01/2025 | By Aishwarya | 685
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy